Managing Venous Thromboembolic Disease in the Cancer Patient

By Scripps Health FEATURING Scott Cameron

73 views

October 18, 2022

Comments 0

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

46.7K views

4 years ago

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

2.2K views

2 years ago

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

4.9K views

1 year ago

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

182 views

8 months ago

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

109 views

8 months ago

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

96 views

8 months ago

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Scripps Health

J. May

315 views

8 months ago

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

669 views

1 year ago

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

819 views

1 year ago

Current Review of Benign Hematology and Coagulopathy

Indy Hematology Review

C. Kessler

1.1K views

1 year ago

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

107 views

3 months ago

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

138 views

6 months ago

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Vanderbilt University Medical Center (VUMC)

M. Baljevic

438 views

1 year ago

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

Robert McBane

293 views

1 year ago

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

466 views

1 year ago

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

103 views

8 months ago

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

50 views

8 months ago

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

577 views

1 year ago

Fred Hutchinson Cancer Center Update in Thromboembolism

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

631 views

1 year ago

EHA 2024 Insights: Low-Molecular-Weight Heparin and VTE in Newly Dia…

Insights from 2024 EHA Annual Meeting

M. Lauw

82 views

4 months ago

Login

Login

Join VuMedi

Managing Venous Thromboembolic Disease in the Cancer Patient

Recommended

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

How do I Recognize and Treat the VEXAS Syndrome?

Cardiotoxicity in Breast Cancer – Case Discussion

Cardio-Oncology: Definitions and Scope

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Management of Simultaneous Venous and Arterial Thromboembolic Disease

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Diagnosis and Goals of Therapy in PV

Current Review of Benign Hematology and Coagulopathy

How the Experts Manage: Cardiotoxicity and IO in NSCLC

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

ADT for Prostate Cancer and Cardiovascular Health Considerations

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Cardiotoxicity in Melanoma – Case Discussion

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Fred Hutchinson Cancer Center Update in Thromboembolism

EHA 2024 Insights: Low-Molecular-Weight Heparin and VTE in Newly Dia…